![Jigar Raythatha](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jigar Raythatha
Direktor/Vorstandsmitglied bei
Flare Therapeutics, Inc.
Profil
Jigar Raythatha is currently Director at TRIANA Biomedicines, Inc., Director at Flare Therapeutics, Inc. since 2023, and Partner at Third Rock Ventures LLC since 2021.
Former positions include President, Chief Executive Officer & Director at Constellation Pharmaceuticals, Inc. from 2017 to 2021; Chairman at Jounce Therapeutics, Inc. from 2022 to 2023; Chief Business Officer at Jounce Therapeutics, Inc. from 2012 to 2017; Principal at Biogen MA, Inc., Pfizer Inc., Shire Regenerative Medicine, Inc., and Red Abbey Venture Partners LLC from 2005 to 2009; and Board Member at American Cancer Society, New England Division, Inc. Education includes an MBA from Columbia Business School and The Trustees of Columbia University in The City of New York, and an undergraduate degree from Rutgers State University of New Jersey conferred in 1998.
Aktive Positionen von Jigar Raythatha
| Unternehmen | Position | Beginn |
|---|---|---|
Third Rock Ventures LLC
 Third Rock Ventures LLC Investment ManagersFinance Third Rock Ventures invests in companies located in the United States. The firm targets companies operating in the fields of the healthcare sector. It provides financing for early stage capital requirements. It acts as a lead investor. | Private Equity Investor | 01.01.2021 |
Santi Therapeutics, Inc.
 Santi Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel therapeutics to treat diseases | Direktor/Vorstandsmitglied | - |
Flare Therapeutics, Inc.
 Flare Therapeutics, Inc. BiotechnologyHealth Technology Engages in research and development of small molecule medicines | Direktor/Vorstandsmitglied | 30.03.2023 |
Ehemalige bekannte Positionen von Jigar Raythatha
| Unternehmen | Position | Ende |
|---|---|---|
| JOUNCE THERAPEUTICS, INC. | Vorsitzender | 03.05.2023 |
| CONSTELLATION PHARMACEUTICALS, INC. | Vorstandsvorsitzender | 15.07.2021 |
| JOUNCE THERAPEUTICS, INC. | Corporate Officer/Principal | 01.02.2017 |
American Cancer Society, New England Division, Inc. | Direktor/Vorstandsmitglied | - |
| PFIZER INC. | Corporate Officer/Principal | - |
Ausbildung von Jigar Raythatha
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
65
Beziehungen ersten Grades
13
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 13 |
|---|---|
Biogen MA, Inc.
 Biogen MA, Inc. BiotechnologyHealth Technology Develops and manufactures drugs related to immunology, neurobiology and oncology | Health Technology |
Pfizer Inc.
 Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
Shire Regenerative Medicine, Inc.
 Shire Regenerative Medicine, Inc. BiotechnologyHealth Technology Manufactures biomedical products | Health Technology |
The Trustees of Columbia University in The City of New York
 The Trustees of Columbia University in The City of New York Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Rutgers State University of New Jersey
 Rutgers State University of New Jersey Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Red Abbey Venture Partners LLC
 Red Abbey Venture Partners LLC Investment ManagersFinance Red Abbey Venture Partners invests in companies located in North America and Europe. The firm focuses on a broad range of sectors. It participates in early and late-stage transactions. It acts as a co-investor and invests in public companies. | Finance |
Third Rock Ventures LLC
Third Rock Ventures LLC Investment ManagersFinance Third Rock Ventures invests in companies located in the United States. The firm targets companies operating in the fields of the healthcare sector. It provides financing for early stage capital requirements. It acts as a lead investor. | Finance |
Constellation Pharmaceuticals, Inc.
 Constellation Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops novel drugs targeting regulators of epigenetic function | Health Technology |
American Cancer Society, New England Division, Inc. | |
Jounce Therapeutics, Inc.
 Jounce Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage immunotherapy company that develops therapies to treat cancer | Health Technology |
Columbia Business School
 Columbia Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Santi Therapeutics, Inc.
Santi Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel therapeutics to treat diseases | Health Technology |
Flare Therapeutics, Inc.
Flare Therapeutics, Inc. BiotechnologyHealth Technology Engages in research and development of small molecule medicines | Health Technology |
Wählen Sie MarketScreener 
